BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND BCL7A, BCL7, 605, ENSG00000110987
108 results:

  • 1. Dietary Exposure and Risk Assessment of Multi-Mycotoxins (AFB1, AFM1, OTA, OTB, DON, T-2 and HT-2) in the Lebanese Food Basket Consumed by Adults: Findings from the Updated Lebanese National Consumption Survey through a Total Diet Study Approach.
    Hoteit M; Abbass Z; Daou R; Tzenios N; Chmeis L; Haddad J; Chahine M; Al Manasfi E; Chahine A; Poh OBJ; El Khoury A
    Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535824
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic liver Disease.
    Elsaid MI; Bridges JFP; Mumtaz K; Li N; Sobotka L; Rustgi VK; Paskett ED
    PLoS One; 2024; 19(3):e0299836. PubMed ID: 38489287
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in cancer.
    Prior O; Macarro C; Navarro V; Monreal C; Ligero M; Garcia-Ruiz A; Serna G; Simonetti S; BraƱa I; Vieito M; Escobar M; Capdevila J; Byrne AT; Dienstmann R; Toledo R; Nuciforo P; Garralda E; Grussu F; Bernatowicz K; Perez-Lopez R
    Radiol Artif Intell; 2024 Mar; 6(2):e230118. PubMed ID: 38294307
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    Cao B; Wang Y; Lu H; Huang C; Yang Y; Shang L; Chen Z; Jiang R; Liu Y; Lin L; Peng P; Wang F; Gong F; Hu H; Cheng C; Yao X; Ye X; Zhou H; Shen Y; Liu C; Wang C; Yi Z; Hu B; Xu J; Gu X; Shen J; Xu Y; Zhang L; Fan J; Tang R; Wang C
    N Engl J Med; 2024 Jan; 390(3):230-241. PubMed ID: 38231624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Wang LF; Guan X; Shen YT; Zhou BY; Sun YK; Li XL; Yin HH; Lu D; Ye X; Hu XY; Yang DH; Xia HS; Wang X; Lu Q; Han H; Xu HX; Zhao CK;
    Abdom Radiol (NY); 2024 Feb; 49(2):458-470. PubMed ID: 38225379
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Factors associated with all-cause mortality in tuberculosis patients in a Malaysian tertiary hospital.
    Wong CK; Ng KS; Choo SQR; Lee CJ; Teo YP; Liew SM; Chinna K; Khoo EM; Ng WL; Tok PSK; Kee YS; Chiang M
    J Infect Dev Ctries; 2023 Aug; 17(8):1138-1145. PubMed ID: 37699097
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
    Tajiri K; Tsukada K; Tokimitsu Y; Motofuji Y; Kawai K; Muraishi N; Murayama A; Hayashi Y; Shimizu Y; Yasuda I
    Oncology; 2024; 102(2):131-140. PubMed ID: 37666216
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Added Value of Cone-Beam Computed Tomography for Detecting Hepatocellular Carcinomas and Feeding Arteries during Transcatheter Arterial Chemoembolization Focusing on Radiation Exposure.
    Kim DJ; Chul-Nam I; Park SE; Kim DR; Lee JS; Kim BS; Choi GM; Kim J; Won JH
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374325
    [No Abstract]    [Full Text] [Related]  

  • 9. Serum cell division cycle 42 in advanced hepatocellular carcinoma patients: Linkage with clinical characteristics and immune checkpoint inhibitor-related treatment outcomes.
    Xu J; Shao R; Zhang X; Yao D; Han S
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102149. PubMed ID: 37247692
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and liver-Related Mortality in the Adult Korean Population.
    Seo YG; Polyzos SA; Park KH; Mantzoros CS
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3322-3335. PubMed ID: 37164111
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis.
    Zheng J; Wei X; Wang N; Pu X; Yang J; Jiang L
    BMC Surg; 2023 Apr; 23(1):100. PubMed ID: 37118720
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of cancers During Chemoradiation Therapy: Real-World Study.
    Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
    JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improving detection performance of hepatocellular carcinoma and interobserver agreement for liver imaging reporting and data system on CT using deep learning reconstruction.
    Okimoto N; Yasaka K; Kaiume M; Kanemaru N; Suzuki Y; Abe O
    Abdom Radiol (NY); 2023 Apr; 48(4):1280-1289. PubMed ID: 36757454
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis.
    Han Y; Zhao W; Wu M; Qian Y
    Medicine (Baltimore); 2022 Dec; 101(51):e32304. PubMed ID: 36595779
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos.
    Zhang L; Jiang Y; Jin Z; Jiang W; Zhang B; Wang C; Wu L; Chen L; Chen Q; Liu S; You J; Mo X; Liu J; Xiong Z; Huang T; Yang L; Wan X; Wen G; Han XG; Fan W; Zhang S
    Cancer Imaging; 2022 May; 22(1):23. PubMed ID: 35549776
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Luo N; Huang X; Ji Y; Jin G; Qin Y; Xiang B; Su D; Tang W
    Eur Radiol; 2022 Aug; 32(8):5623-5632. PubMed ID: 35294586
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
    Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
    Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical records.
    Asai Y; Yamamoto T; Sato Y
    J Infect Chemother; 2022 May; 28(5):690-695. PubMed ID: 35148944
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Early detection of treatment futility in patients with metastatic colorectal cancer.
    Rattner JI; Kopciuk KA; Vogel HJ; Tang PA; Shapiro JD; Tu D; Jonker DJ; Siu LL; O'Callaghan CJ; Bathe OF
    Oncotarget; 2022; 13():61-72. PubMed ID: 35028011
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Effect of HBV infection pattern on prevalence of fatty liver disease in Jinchang cohort].
    Zhang WL; Bai YN; Zhang DS; Zhao YY; Yin C; Huo YB; Ding J; Ba YP; Li N; Gan T; Wang YF; Cheng N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Mar; 42(3):488-492. PubMed ID: 34814418
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 6.